A network pharmacology approach confirms Biejiaxiaozheng pills combat hepatic fibrosis by modulating macrophage inflammation and hepatic stellate cell activation
Abstract Biejiaxiaozheng (BJXZ) pills, a traditional Chinese medicine, have demonstrated anti-fibrotic effects; however, their mechanisms in treating liver fibrosis remain unclear. This study aimed to explore the active targets and underlying mechanisms of BJXZ pills using network pharmacology and e...
Saved in:
| Main Authors: | Weibin Wu, Yanli Liao, Jiefei Liang, Mi Huang, Guifeng Zhang, Yuying Hu, Chao Yuan, Duanzhou Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-09002-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic Effect of Biejiaxiaozheng Pills on Carbon Tetrachloride-Induced Hepatic Fibrosis in Rats through the NF-κB/Nrf2 Pathway
by: Weibin Wu, et al.
Published: (2021-01-01) -
Hepatic stellate cell-specific Kcnma1 deletion mitigates metabolic dysfunction-associated steatotic liver disease progression via upregulating Amphiregulin secretion
by: Yunhan Zou, et al.
Published: (2025-07-01) -
Study on the mechanism of action of Qiju Dihuang Pills in the treatment of dry eye based on network pharmacology and molecular docking
by: Xu Chen, et al.
Published: (2025-05-01) -
Diallyl Trisulfide From Garlic Regulates RAB18 Phase Separation to Inhibit Lipophagy and Induce Cuproptosis in Hepatic Stellate Cells for Antifibrotic Effects
by: Haoyuan Tian, et al.
Published: (2025-06-01) -
Exploring the Mechanism of Yougui Pill against Aging Based on Network Pharmacology and Molecular Docking Study
by: Haiyan Yang, et al.
Published: (2025-03-01)